SG Americas Securities
CRBP icon

SG Americas Securities’s Corbus Pharmaceuticals CRBP Stock Holding History

SG Americas Securities’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,331
Closed -$151K – 3218
2024
Q3 		$151K Buy
+7,331
New +$375K ﹤0.01% 2726
2021
Q2 		– Sell
-353
Closed -$21K – 2911
2021
Q1 		$21K Sell
353
-3,192
-90% -$210K ﹤0.01% 3207
2020
Q4 		$133K Sell
3,545
-37,392
-91% -$1.4M ﹤0.01% 2886
2020
Q3 		$2.21M Buy
40,937
+37,909
+1,252% +$6.87M 0.02% 688
2020
Q2 		$762K Buy
3,028
+2,605
+616% +$526K 0.01% 1681
2020
Q1 		$67K Buy
+423
New +$71.5K ﹤0.01% 3115
2017
Q2 		– Sell
-598
Closed -$148K – 3222
2017
Q1 		$148K Buy
+598
New +$147K ﹤0.01% 2668

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return